335 related articles for article (PubMed ID: 17689092)
21. Changes in the concentration of plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) after total joint replacement in patients with arthritis.
Omura K; Takahashi M; Omura T; Miyamoto S; Kushida K; Sano Y; Miura M; Nagano A
Clin Rheumatol; 2002 Nov; 21(6):488-92. PubMed ID: 12447632
[TBL] [Abstract][Full Text] [Related]
22. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory Cytokines and Matrix Metalloproteinases in the Synovial Fluid After Intra-articular Ankle Fracture.
Adams SB; Setton LA; Bell RD; Easley ME; Huebner JL; Stabler T; Kraus VB; Leimer EM; Olson SA; Nettles DL
Foot Ankle Int; 2015 Nov; 36(11):1264-71. PubMed ID: 26449389
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
[TBL] [Abstract][Full Text] [Related]
25. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells.
Doss F; Menard J; Hauschild M; Kreutzer HJ; Mittlmeier T; Müller-Steinhardt M; Müller B
Scand J Rheumatol; 2007; 36(2):136-9. PubMed ID: 17476620
[TBL] [Abstract][Full Text] [Related]
26. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
27. [Destruction of articular cartilage].
Koike T
Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
[TBL] [Abstract][Full Text] [Related]
28. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
Tziakas DN; Chalikias GK; Parissis JT; Hatzinikolaou EI; Papadopoulos ED; Tripsiannis GA; Papadopoulou EG; Tentes IK; Karas SM; Chatseras DI
Int J Cardiol; 2004 Apr; 94(2-3):269-77. PubMed ID: 15093992
[TBL] [Abstract][Full Text] [Related]
29. Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients.
Loo WT; Sasano H; Chow LW
Biomed Pharmacother; 2007 Oct; 61(9):548-52. PubMed ID: 17904786
[TBL] [Abstract][Full Text] [Related]
30. Differential induction and regulation of matrix metalloproteinases in osteoarthritic tissue and fluid synovial fibroblasts.
Fuchs S; Skwara A; Bloch M; Dankbar B
Osteoarthritis Cartilage; 2004 May; 12(5):409-18. PubMed ID: 15094140
[TBL] [Abstract][Full Text] [Related]
31. Synovial fluid cartilage metabolism marker concentrations in osteonecrosis of the femoral head compared with osteoarthrosis of the hip.
Iwase T; Hasegawa Y; Ishiguro N; Ito T; Iwasada S; Kitamura S; Iwata H
J Rheumatol; 1998 Mar; 25(3):527-31. PubMed ID: 9517775
[TBL] [Abstract][Full Text] [Related]
32. Subchondral cyst development and MMP-1 expression during progression of osteoarthritis: an immunohistochemical study.
Kaspiris A; Khaldi L; Grivas TB; Vasiliadis E; Kouvaras I; Dagkas S; Chronopoulos E; Papadimitriou E
Orthop Traumatol Surg Res; 2013 Sep; 99(5):523-9. PubMed ID: 23809184
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of inflammatory cytokines and matrix metalloproteinases in pseudophakic corneal edema.
Shoshani Y; Pe'er J; Doviner V; Frucht-Pery J; Solomon A
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1940-7. PubMed ID: 15914607
[TBL] [Abstract][Full Text] [Related]
35. Systemic inflammatory markers in patients with aortic sclerosis.
Rugina M; Caras I; Jurcut R; Jurcut C; Serbanescu F; Salageanu A; Apetrei E
Roum Arch Microbiol Immunol; 2007; 66(1-2):10-6. PubMed ID: 18928057
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of intermittent fluid pressure of low physiological magnitude on cartilage and inflammation in osteoarthritis. An in vitro study.
van Valburg AA; van Roy HL; Lafeber FP; Bijlsma JW
J Rheumatol; 1998 Mar; 25(3):515-20. PubMed ID: 9517773
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
Zdzisińska B; Walter-Croneck A; Dmoszyńska A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2006; 54(4):289-96. PubMed ID: 16868721
[TBL] [Abstract][Full Text] [Related]
38. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis.
Sutton S; Clutterbuck A; Harris P; Gent T; Freeman S; Foster N; Barrett-Jolley R; Mobasheri A
Vet J; 2009 Jan; 179(1):10-24. PubMed ID: 17911037
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory status in patients with chronic renal failure: the role of PTX3 and pro-inflammatory cytokines.
Malaponte G; Libra M; Bevelacqua Y; Merito P; Fatuzzo P; Rapisarda F; Cristina M; Naselli G; Stivala F; Mazzarino MC; Castellino P
Int J Mol Med; 2007 Oct; 20(4):471-81. PubMed ID: 17786277
[TBL] [Abstract][Full Text] [Related]
40. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Wu CL; Lu KH
Connect Tissue Res; 2004; 45(3):142-50. PubMed ID: 15512768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
